Differential effects of three dopamine receptor agonists in MPTP-treated monkeys
- 47 Downloads
The behavioral effects of cabergoline, pergolide and bromocriptine were investigated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned parkinsonian cynomolgus monkeys with attention to the induction of hyperactivity, as evidenced by irritability, excitability and aggressiveness. All three drugs improved the parkinsonism in a dose-dependent fashion following a single injection. Among the three dopamine (DA) receptor agonists used, the antiparkinsonian effect of pergolide was the strongest and had an immediate effect, while cabergoline showed the longest duration of the antiparkinsonian effect and was least potent in inducing hyperactivity.
KeywordsDopamine receptor agonists Parkinson's disease parkinsonism hyperactivity
Unable to display preview. Download preview PDF.
- Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80: 4546–4550PubMedGoogle Scholar
- Clemens JA, Okimura T, Smalstig EB (1993) Dopamine agonist activities of pergolide, its metabolites, and bromocriptine as measured by prolactin inhibition, compulsive turning, and stereotypic behavior. Arzneimittelforschung/Drug Res 43: 281–286Google Scholar
- Steiger MJ, Quinn NP (1992) Levodopa-based therapy. In: Koller WC (ed) Handbook of Parkinson's disease, 2nd ed. Marcel Dekker, New York, pp 391–410Google Scholar